These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1139 related items for PubMed ID: 6287961

  • 1. Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.
    Bentz MS, Cohen C, Demers LM, Budgeon LR.
    Arch Pathol Lab Med; 1982 Sep; 106(9):476-80. PubMed ID: 6287961
    [Abstract] [Full Text] [Related]

  • 2. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T, Herawi M, Epstein JI, Illei PB.
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [Abstract] [Full Text] [Related]

  • 3. Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
    Arora B, Chhabra A, Yadav MS, Arora DR.
    Indian J Pathol Microbiol; 1990 Jul; 33(3):235-8. PubMed ID: 1965432
    [Abstract] [Full Text] [Related]

  • 4. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
    Jack GS, Brash AR, Olson SJ, Manning S, Coffey CS, Smith JA, Shappell SB.
    Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
    [Abstract] [Full Text] [Related]

  • 5. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
    Genega EM, Hutchinson B, Reuter VE, Gaudin PB.
    Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
    [Abstract] [Full Text] [Related]

  • 6. Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
    Broghamer WL, Richardson ME, Faurest S, Parker JE.
    Acta Cytol; 1985 Nov; 29(3):274-8. PubMed ID: 3890441
    [Abstract] [Full Text] [Related]

  • 7. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
    Iczkowski KA, Pantazis CG, McGregor DH, Wu Y, Tawfik OW.
    Cancer; 2002 Dec 15; 95(12):2487-93. PubMed ID: 12467061
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI.
    Am J Surg Pathol; 2007 Aug 15; 31(8):1246-55. PubMed ID: 17667550
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
    Lane Z, Hansel DE, Epstein JI.
    Am J Surg Pathol; 2008 Sep 15; 32(9):1322-6. PubMed ID: 18670358
    [Abstract] [Full Text] [Related]

  • 10. Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
    Bartziota EV.
    Acta Cytol; 1986 Sep 15; 30(5):497-500. PubMed ID: 2430390
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunohistochemical identification of prostatic acid phosphatase: correlation of tumor grade with acid phosphatase distribution.
    Bates RJ, Chapman CM, Prout GR, Lin CW.
    J Urol; 1982 Mar 15; 127(3):574-80. PubMed ID: 6174741
    [Abstract] [Full Text] [Related]

  • 15. Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
    Puebla-Mora AG, Heras A, Cano-Valdez AM, Domínguez-Malagón H.
    Ann Diagn Pathol; 2006 Aug 15; 10(4):205-8. PubMed ID: 16844561
    [Abstract] [Full Text] [Related]

  • 16. Correlation of survival with quantitative tissue staining of prostate specific acid phosphatase in patients with prostate carcinoma by using microscopic image analysis: a preliminary report of correlative studies on RTOG protocols 75-06, 77-06, and 83-07.
    Zhou R, Sause WT, Hammond EH, Rubin P, Perez C, Pilepich MV, Asbell SD, Parker DL.
    Int J Radiat Oncol Biol Phys; 1995 Nov 01; 33(4):823-9. PubMed ID: 7591889
    [Abstract] [Full Text] [Related]

  • 17. Prostatic adenocarcinoma metastases mimicking small cell carcinoma on fine-needle aspiration.
    Parwani AV, Ali SZ.
    Diagn Cytopathol; 2002 Aug 01; 27(2):75-9. PubMed ID: 12203872
    [Abstract] [Full Text] [Related]

  • 18. Lewis Y antigen as detected by the monoclonal antibody BR96 is expressed strongly in prostatic adenocarcinoma.
    Myers RB, Srivastava S, Grizzle WE.
    J Urol; 1995 May 01; 153(5):1572-4. PubMed ID: 7714977
    [Abstract] [Full Text] [Related]

  • 19. The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
    Bruce AW, Mahan DE, Belville WD.
    Urol Clin North Am; 1980 Oct 01; 7(3):645-52. PubMed ID: 7456177
    [Abstract] [Full Text] [Related]

  • 20. Expression of tumor-associated glycoprotein 72 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Myers RB, Schlom J, Srivastava S, Grizzle WE.
    Mod Pathol; 1995 Apr 01; 8(3):260-5. PubMed ID: 7617651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.